Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor‐mutated lung cancer model

Non‐small‐cell lung cancers with epidermal growth factor receptor (EGFR) mutations are sensitive to EGFR tyrosine kinase inhibitors (TKIs); however, unlike cytotoxic agents, it is generally accepted that minimal doses of drugs inhibiting target molecules are sufficient when molecular‐targeted agents...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Sci
Hauptverfasser: Hayakawa, Hiromi, Ichihara, Eiki, Ohashi, Kadoaki, Ninomiya, Takashi, Yasugi, Masayuki, Takata, Saburo, Sakai, Katsuya, Matsumoto, Kunio, Takigawa, Nagio, Tanimoto, Mitsune, Kiura, Katsuyuki
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2013
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654246/
https://ncbi.nlm.nih.gov/pubmed/24033722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12284
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge